ERS 2026: GB-0895 clinical results show potential of next-gen anti-TSLP for asthma
As a lymphocyte-stimulating cytokine, TSLP has been shown to drive the inflammatory response in the airways of patients with severe asthma.
As a lymphocyte-stimulating cytokine, TSLP has been shown to drive the inflammatory response in the airways of patients with severe asthma.